AR073848A1 - Utilizacion de la 4-(3-(hexahidrociclopenta(c)pirrol-2(1h)-il)propoxi)benzamida para la obtencion de medicamentos destinados al tratamiento de los trastornos del sueno. composicion farmaceutica. - Google Patents

Utilizacion de la 4-(3-(hexahidrociclopenta(c)pirrol-2(1h)-il)propoxi)benzamida para la obtencion de medicamentos destinados al tratamiento de los trastornos del sueno. composicion farmaceutica.

Info

Publication number
AR073848A1
AR073848A1 ARP090103933A ARP090103933A AR073848A1 AR 073848 A1 AR073848 A1 AR 073848A1 AR P090103933 A ARP090103933 A AR P090103933A AR P090103933 A ARP090103933 A AR P090103933A AR 073848 A1 AR073848 A1 AR 073848A1
Authority
AR
Argentina
Prior art keywords
benzamide
treatment
propoxy
disorders
hexahydrociclopenta
Prior art date
Application number
ARP090103933A
Other languages
English (en)
Inventor
Elisabeth Mocaer
Florence Keime-Guibert
Pierre Lestage
Laurence Danober
Anita Roger
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR073848A1 publication Critical patent/AR073848A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Utilizacion de la 4-{3-[hexadihidrociclopenta[c]pirrol-2-(1H)-il]propoxi}benzamida para la obtencion de medicamentos destinados al tratamiento de los trastornos el sueno. Reivindicacion 5: Composiciones farmacéuticas que contienen 4-{3-[hexadihidrociclopenta[c]pirrol-2-(1H)-il]propoxi}benzamida, o una de sus sales de adicion a un ácido o a una base farmacéuticamente aceptable, en combinacion con uno o varios excipientes farmacéuticamente aceptables, utiles para el tratamiento de los trastornos del sueno que son la narcolepsia, las hipersomnias que aparecen durante el síndrome de apnea obstructiva del sueno o el síndrome de hiperactividad con déficits atencionales y las somnolencias diurnas, así como el tratamiento de los trastornos del sueno asociados al envejecimiento cerebral, a las enfermedades neurodegenerativas o a los traumatismos craneales. Reivindicacion 8: Composiciones farmacéuticas segun una de las reivindicaciones 5 a 7 caracterizadas porque la 4-{3-[hexahidrociclopenta[c]pirrol-2-(1H)-il]propoxi}benzamida está presente en la forma de un oxalato o de un hidrocloruro.
ARP090103933A 2008-10-16 2009-10-14 Utilizacion de la 4-(3-(hexahidrociclopenta(c)pirrol-2(1h)-il)propoxi)benzamida para la obtencion de medicamentos destinados al tratamiento de los trastornos del sueno. composicion farmaceutica. AR073848A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0805721A FR2937251B1 (fr) 2008-10-16 2008-10-16 Utilisation du 4-{3-°hexahydrocyclopenta°c!pyrrol-2(1h)-yl! propoxy}benzamide pour l'obtention de medicaments destines au traitement des troubles du sommeil

Publications (1)

Publication Number Publication Date
AR073848A1 true AR073848A1 (es) 2010-12-09

Family

ID=40416951

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090103933A AR073848A1 (es) 2008-10-16 2009-10-14 Utilizacion de la 4-(3-(hexahidrociclopenta(c)pirrol-2(1h)-il)propoxi)benzamida para la obtencion de medicamentos destinados al tratamiento de los trastornos del sueno. composicion farmaceutica.

Country Status (3)

Country Link
AR (1) AR073848A1 (es)
FR (1) FR2937251B1 (es)
WO (1) WO2010043787A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2974729B1 (fr) * 2011-05-02 2013-04-19 Servier Lab Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide et un inhibiteur de l'acetylcholinesterase et les compositions pharmaceutiques qui la contiennent
FR2976285B1 (fr) * 2011-06-08 2013-05-24 Servier Lab Procede de synthese et forme cristalline du chlorhydrate de 4-{3-[cis-hexahydrocypenta[c]pyrrol-2(1h)-yl]propoxy}benzamide ainsi que les compositions pharmaceutiques qui la contiennent
FR2976286B1 (fr) * 2011-06-08 2013-05-24 Servier Lab 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent
FR2983732B1 (fr) * 2011-12-09 2013-11-22 Servier Lab Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}pharmaceutiques qui la contiennent
FR2999179A1 (fr) * 2012-12-07 2014-06-13 Servier Lab Procede de synthese d'un sel d'addition a un acide pharmaceutiquement acceptable du 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, ainsi que les formes cristallines associees

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
FR2937251B1 (fr) 2011-03-18
WO2010043787A1 (fr) 2010-04-22
FR2937251A1 (fr) 2010-04-23

Similar Documents

Publication Publication Date Title
AR085219A1 (es) 6-cicloalquil-pirazolopirimidinonas para el tratamiento de trastornos del snc
CY1122610T1 (el) Αλκοξυ πυραζολια ως ενεργοποιητες διαλυτης γουανυλικης κυκλασης
EA201290519A1 (ru) Положительные аллостерические модуляторы рецептора хинолин амида m1
AR073848A1 (es) Utilizacion de la 4-(3-(hexahidrociclopenta(c)pirrol-2(1h)-il)propoxi)benzamida para la obtencion de medicamentos destinados al tratamiento de los trastornos del sueno. composicion farmaceutica.
EP2582676A4 (en) POSITIVE ALLOSTERIC TETRAHYDROCHINOLINE AMID M1 RECEPTOR MODULATORS
RU2015143610A (ru) Лечение катаплексии
UY26863A1 (es) Derivados de la piperazina
BR112013004443A8 (pt) composições farmacêuticas de (r)-1-(2,2-difluorbenzo[d] [1,3]dioxol-5-il)-n-(1-(2,3-di-hidróxipropil)-6-flúor-2-(1-hidróxi-2-metilpropan-2-il)-1h-indol-5-il)ciclopropano carboxamida e administração das mesmas
MX2013008056A (es) 1,4-oxazepinas como inhibidores de beta-secretasa 1 (bace1) y/o beta-secretasa 2 (bace2).
JP2012504560A5 (es)
JP2019518732A5 (es)
JP2020503246A5 (es)
EA200801488A1 (ru) Замещенные фенетиламины, обладающие серотонинергической и/или норэпинефринергической активностью
CY1114400T1 (el) Θεραπευτικες εφαρμογες των παραγωγων κιναζολινεδιονης
ATE538100T1 (de) Aminotetrahydroindazoloessigsäuren
EA201792071A3 (ru) Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения
RU2018134262A (ru) Производное 5-этил-4-метил-пиразол-3-карбоксамида, обладающее активностью агониста taar
UY27204A1 (es) Derivados de pieracina
CO7200248A2 (es) Derivados de etinilo como moduladores de la actividad de los receptores mglur5
CL2012002259A1 (es) Forma cristalina de 4-{(1s,2s)-2-[84-ciclobutilpiperazin-1-il-carbonil]ciclopropil}benzamida; composicion farmacéutica; y su uso para tratar enfermedades tales como esquizofrenia, narcolepsia, somnolencia diurna excesiva, obesidad, trastornos por deficit de atencion con hiperactividad, dolor, entre otras.
DOP2009000209A (es) Sales de adición de ácido, hidratos y polimorfos de la etil-amida del ácido 5-(2,4-dihidroxi-5-isopropilfenil)-4-(4-morfolin-4-il-metil-fenil)-isoxazol-3-carboxílico, y formulaciones que comprenden estas formas
IL206615A (en) The History of Pipridine Sulfonamide, the Process for Preparing it, Medicines Containing It, and Their Use in the Preparation of Medication for Treatment
IN2014KN01113A (es)
AR089112A1 (es) Asociacion entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1h)-il]propoxi}benzamida y un antagonista de los receptores nmda y las composiciones farmaceuticas que la contienen
PH12015500346A1 (en) Ethynyl derivatives as modulators of mglur5 receptor activity

Legal Events

Date Code Title Description
FB Suspension of granting procedure